scispace - formally typeset
Open AccessJournal ArticleDOI

Activation of heparin cofactor II by dermatan sulfate.

Douglas M. Tollefsen, +2 more
- 10 Jun 1983 - 
- Vol. 258, Iss: 11, pp 6713-6716
Reads0
Chats0
TLDR
It is suggested that HCII is the only thrombin inhibitor in human plasma that can be activated by dermatan sulfate.
About
This article is published in Journal of Biological Chemistry.The article was published on 1983-06-10 and is currently open access. It has received 428 citations till now. The article focuses on the topics: Heparin cofactor II & Dermatan sulfate.

read more

Citations
References
More filters
Journal ArticleDOI

A modified uronic acid carbazole reaction

TL;DR: It has been found possible to distinguish betweenHeparin, heparin derivatives, and other polyuronides of connective tissue by comparing the effect of chlorides on the color yield in both procedures by modifying Dische's carbazole reaction for uronic acid in the presence of borate.
Journal ArticleDOI

The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

TL;DR: It is suggested that heparin binds to the inhibitor and causes a conformational change which results in a more favorable exposure of the arginine reactive site, allowing a rapid interaction with thrombin.
Journal ArticleDOI

Glycosaminoglycans and their binding to biological macromolecules.

TL;DR: STRUCTURE and BIOSYNTHESIS of GL YCOSAMINOGL YCANS: Foundations and biosynthesis of GL ycans.
Journal ArticleDOI

Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.

TL;DR: A previously unrecognized heparin-dependent inhibitor of thrombin from human plasma is isolated and is a relatively ineffective inhibitor of coagulation factor Xa.
Journal ArticleDOI

The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.

TL;DR: It is demonstrated that binding of heparin to antithrombin is required for the mucopolysaccharide-dependent enhancement in the rates of neutralization of thrombin, factor IXa, factor Xa, or plasmin by the protease inhibitor.
Related Papers (5)